{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T17:37:43Z","timestamp":1785173863013,"version":"3.55.0"},"reference-count":66,"publisher":"American Society of Tropical Medicine and Hygiene","issue":"4_Suppl","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,1]]},"abstract":"<jats:title>ABSTRACT.<\/jats:title>\n<jats:p>Lymphedema, hydrocele, and acute adenolymphangitis (ADL) are chronically disabling consequences in patients with lymphatic filariasis (LF). Provision of morbidity management and disability prevention and concurrent mass drug administration of anthelmintics are two pillars for elimination of LF. This study assessed the impact of strict hygiene protocols with or without doxycycline on the progression of filarial lymphedema. A randomized, placebo-controlled, double-blind trial was conducted in two regions in Tanzania. We enrolled 362 participants with lymphedema stages 1\u20133 assigned into three treatment groups of doxycycline 200 mg once daily, doxycycline 100 mg once daily, or matching placebo for 42 days in addition to hygiene measures. The participants were followed every 2 months for 2 years. Twenty-four months after treatment onset, 17.7% of participants displayed improved limb conditions, including 15\/104 (14.4%) in the doxycycline 200 mg group, 16\/105 (15.2%) in the doxycycline 100 mg group, and 25\/107 (23.4%) in the placebo group. During the first 6 months after treatment, the number of participants experiencing an ADL attack was significantly lower in the doxycycline groups than in the placebo group. The study also found that hygiene was one of the factors associated with preventing the occurrence of acute attacks over the whole study period. Doxycycline 100 mg was a significant factor for the halt of progression (odds ratio: 0.53, <jats:italic>P<\/jats:italic> = 0.0239) when both legs if affected at baseline were considered. These findings emphasize the importance of practicing hygiene in reducing the occurrence of ADL attacks and the benefits of doxycycline with regards to acute attacks and halt of progression.<\/jats:p>","DOI":"10.4269\/ajtmh.24-0049","type":"journal-article","created":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T14:29:08Z","timestamp":1724768948000},"page":"33-51","source":"Crossref","is-referenced-by-count":5,"title":["Efficacy of Intensified Hygiene Measures with or without the Addition of Doxycycline in the Management of Filarial Lymphedema: A Randomized Double-Blind, Placebo-Controlled Clinical Trial in Tanzania"],"prefix":"10.4269","volume":"111","author":[{"given":"Abdallah","family":"Ngenya","sequence":"first","affiliation":[{"name":"National Institute for Medical Research, Dar es Salaam, Tanzania;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ute","family":"Klarmann-Schulz","sequence":"additional","affiliation":[{"name":"Institute for Medical Microbiology, Immunology and Parasitology, University Hospital Bonn, Bonn, Germany;"},{"name":"German Center for Infection Research, partner site Bonn-Cologne, Bonn, Germany;"},{"name":"Institute for Medical Biometry, Informatics and Epidemiology, University Hospital Bonn, Bonn, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winfrida","family":"John","sequence":"additional","affiliation":[{"name":"National Institute for Medical Research, Dar es Salaam, Tanzania;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia Jebett","family":"Korir","sequence":"additional","affiliation":[{"name":"Institute for Medical Microbiology, Immunology and Parasitology, University Hospital Bonn, Bonn, Germany;"},{"name":"German Center for Infection Research, partner site Bonn-Cologne, Bonn, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"Kamugisha","sequence":"additional","affiliation":[{"name":"National Institute for Medical Research, Dar es Salaam, Tanzania;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Nadal","sequence":"additional","affiliation":[{"name":"Institute for Medical Microbiology, Immunology and Parasitology, University Hospital Bonn, Bonn, Germany;"},{"name":"Institute for Medical Biometry, Informatics and Epidemiology, University Hospital Bonn, Bonn, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Moshi","sequence":"additional","affiliation":[{"name":"National Institute for Medical Research, Dar es Salaam, Tanzania;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arcangelo","family":"Ricchiuto","sequence":"additional","affiliation":[{"name":"Institute for Medical Microbiology, Immunology and Parasitology, University Hospital Bonn, Bonn, Germany;"},{"name":"Institute for Medical Biometry, Informatics and Epidemiology, University Hospital Bonn, Bonn, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ndekya","family":"Oriyo","sequence":"additional","affiliation":[{"name":"National Institute for Medical Research, Dar es Salaam, Tanzania;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah Mary","family":"Sullivan","sequence":"additional","affiliation":[{"name":"Neglected Tropical Diseases Support Center, Task Force for Global Health, Decatur, Georgia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Laizer","sequence":"additional","affiliation":[{"name":"Kilimanjaro Clinical Research Institute, Moshi, Tanzania;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Horton","sequence":"additional","affiliation":[{"name":"Tropical Projects, Hitchin, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"Demitrius","sequence":"additional","affiliation":[{"name":"National Institute for Medical Research, Dar es Salaam, Tanzania;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Feichtner","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases and Tropical Medicine, Medical Center of the Ludwig-Maximilians-University, Munich, Germany;"},{"name":"German Center for Infection Research, partner site Munich, Munich, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas F.","family":"Marandu","sequence":"additional","affiliation":[{"name":"University of Dar es Salaam\u2013Mbeya College of Health and Allied Sciences, Mbeya, Tanzania;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuph","family":"Mgaya","sequence":"additional","affiliation":[{"name":"National Institute for Medical Research, Dar es Salaam, Tanzania;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelika","family":"Kellings","sequence":"additional","affiliation":[{"name":"Clinical Study Core Unit Bonn, Institute of Clinical Chemistry and Clinical Pharmacology, University of Bonn, Bonn, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inge","family":"Kroidl","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases and Tropical Medicine, Medical Center of the Ludwig-Maximilians-University, Munich, Germany;"},{"name":"German Center for Infection Research, partner site Munich, Munich, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Ogondiek","sequence":"additional","affiliation":[{"name":"National Institute for Medical Research, Dar es Salaam, Tanzania;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janina M.","family":"Kuehlwein","sequence":"additional","affiliation":[{"name":"Institute for Medical Microbiology, Immunology and Parasitology, University Hospital Bonn, Bonn, Germany;"},{"name":"German Center for Infection Research, partner site Bonn-Cologne, Bonn, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard","family":"Masagati","sequence":"additional","affiliation":[{"name":"National Institute for Medical Research, Dar es Salaam, Tanzania;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Mackenzie","sequence":"additional","affiliation":[{"name":"Neglected Tropical Diseases Support Center, Task Force for Global Health, Decatur, Georgia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maureen","family":"Mosoba","sequence":"additional","affiliation":[{"name":"National Institute for Medical Research, Dar es Salaam, Tanzania;"},{"name":"Center for International Health, Ludwig-Maximilians-University, Munich, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sacha","family":"Horn","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases and Tropical Medicine, Medical Center of the Ludwig-Maximilians-University, Munich, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kheri","family":"Kagya","sequence":"additional","affiliation":[{"name":"Regional Medical Office, Lindi Municipal Council, Lindi Region, Tanzania;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Wanji","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Parasitology, University of Buea, Buea, Cameroon;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilfred","family":"Mandara","sequence":"additional","affiliation":[{"name":"National Institute for Medical Research, Dar es Salaam, Tanzania;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda Batsa","family":"Debrah","sequence":"additional","affiliation":[{"name":"Kumasi Centre for Collaborative Research in Tropical Medicine, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana;"},{"name":"Department of Clinical Microbiology, School of Medicine and Dentistry, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana;"},{"name":"German\u2013West African Center for Global Health and Pandemic Prevention, partner site Kumasi, Kumasi, Ghana;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric A.","family":"Ottesen","sequence":"additional","affiliation":[{"name":"Neglected Tropical Diseases Support Center, Task Force for Global Health, Decatur, Georgia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander Yaw","family":"Debrah","sequence":"additional","affiliation":[{"name":"Kumasi Centre for Collaborative Research in Tropical Medicine, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana;"},{"name":"German\u2013West African Center for Global Health and Pandemic Prevention, partner site Kumasi, Kumasi, Ghana;"},{"name":"Faculty of Allied Health Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Upendo","family":"Mwingira","sequence":"additional","affiliation":[{"name":"National Institute for Medical Research, Dar es Salaam, Tanzania;"},{"name":"RTI International, Washington, District of Columbia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Achim","family":"Hoerauf","sequence":"additional","affiliation":[{"name":"Institute for Medical Microbiology, Immunology and Parasitology, University Hospital Bonn, Bonn, Germany;"},{"name":"German Center for Infection Research, partner site Bonn-Cologne, Bonn, Germany;"},{"name":"German\u2013West African Center for Global Health and Pandemic Prevention, partner site Bonn, Bonn, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akili","family":"Kalinga","sequence":"additional","affiliation":[{"name":"National Institute for Medical Research, Dar es Salaam, Tanzania;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2795","reference":[{"key":"b1","year":"2021"},{"key":"b2","year":"2023"},{"key":"b3","series-title":"Int J Environ Res Public Health","first-page":"316","article-title":"Lymphatic filariasis: A systematic review on morbidity and its repercussions in countries in the Americas","volume":"19","author":"Medeiros","year":"2022"},{"key":"b4","series-title":"Lymphatic Filariasis: Managing Morbidity and Preventing Disability: An Aide-M\u00e9moire for National Programme Managers","year":"2021"},{"key":"b5","series-title":"Ending the Neglect to Attain the Sustainable Development Goals: A Road Map for Neglected Tropical Diseases 2021\u20132030","year":"2020"},{"key":"b6","series-title":"Int Health","first-page":"i15","article-title":"Leaving no one behind: A neglected tropical disease indicator and tracers for the Sustainable Development Goals","volume":"8","author":"Fitzpatrick","year":"2016"},{"key":"b7","series-title":"Parasit Vectors","first-page":"155","article-title":"The design and development of a multicentric protocol to investigate the impact of adjunctive doxycycline on the management of peripheral lymphoedema caused by lymphatic filariasis and podoconiosis","volume":"13","author":"Horton","year":"2020"},{"key":"b8","series-title":"Rev Soc Bras Med Trop","first-page":"325","article-title":"Controlling morbidity and interrupting transmission: Twin pillars of lymphatic filariasis elimination","volume":"32","author":"Seim","year":"1999"},{"key":"b9","year":"2021"},{"key":"b10","series-title":"PLoS Negl Trop Dis","first-page":"e0005748","article-title":"Lymphatic filariasis patient identification in a large urban area of Tanzania: An application of a community-led mHealth system","volume":"11","author":"Mwingira","year":"2017"},{"key":"b11","series-title":"BMC Health Serv Res","first-page":"924","article-title":"The viability of utilising phone-based text messages in data capture and reporting morbidities due to lymphatic filariasis by community health workers: A qualitative study in Kilwa district, Tanzania","volume":"22","author":"Kalinga","year":"2022"},{"key":"b12","series-title":"Afro-Egyptian J Infect Endemic Dis","first-page":"369","article-title":"Community participation in the mass drug administration and their knowledge, attitudes, and practices on management of filarial lymphoedema in Lindi District, Tanzania: A cross-sectional study","volume":"11","author":"John","year":"2021"},{"key":"b13","series-title":"Am Trop Med Hyg","first-page":"3","article-title":"Managing lymphedema induced by lymphatic filariasis: Implementing and improving care at the individual and programmatic levels","volume":"111","author":"Mackenzie","year":"2024"},{"key":"b14","series-title":"Front Pharmacol","first-page":"828513","article-title":"Pharmacological treatment of secondary lymphedema","volume":"13","author":"Brown","year":"2022"},{"key":"b15","series-title":"Cureus","first-page":"e6300","article-title":"Pharmacotherapy agents in lymphedema treatment: A systematic review","volume":"11","author":"Forte"},{"key":"b16","series-title":"Infect Dis Poverty","first-page":"20","article-title":"Lymphatic filariasis, infection status in Culex quinquefasciatus and Anopheles species after six rounds of mass drug administration in Masasi District, Tanzania","volume":"10","author":"Lupenza","year":"2021"},{"key":"b17","series-title":"J Foot Ankle Res","first-page":"51","article-title":"Foot care practice and associated factors among patients with lymphoedema in Boreda district, Gamo zone, southern Ethiopia, 2020. Implications for elimination of podoconiosis and lymphatic filariasis","volume":"14","author":"Churko","year":"2021"},{"key":"b18","series-title":"PLoS Pathog","first-page":"e92","article-title":"Doxycycline reduces plasma VEGF-C\/sVEGFR-3 and improves pathology in lymphatic filariasis","volume":"2","author":"Debrah","year":"2006"},{"key":"b19","series-title":"Lancet","first-page":"1242","article-title":"Endosymbiotic bacteria in worms as targets for a novel chemotherapy in filariasis","volume":"355","author":"Hoerauf","year":"2000"},{"key":"b20","series-title":"Lancet","first-page":"1415","article-title":"Depletion of Wolbachia endobacteria in Onchocerca volvulus by doxycycline and microfilaridermia after ivermectin treatment","volume":"357","author":"Hoerauf","year":"2001"},{"key":"b21","series-title":"Lancet","first-page":"2116","article-title":"Macrofilaricidal activity after doxycycline treatment of Wuchereria bancrofti: A double-blind, randomised placebo-controlled trial","volume":"365","author":"Taylor","year":"2005"},{"key":"b22","series-title":"Med Microbiol Immunol (Berl)","first-page":"295","article-title":"Wolbachia endobacteria depletion by doxycycline as antifilarial therapy has macrofilaricidal activity in onchocerciasis: A randomized placebo-controlled study","volume":"197","author":"Hoerauf","year":"2008"},{"key":"b23","series-title":"PLoS Negl Trop Dis","first-page":"e660","article-title":"Macrofilaricidal activity after doxycycline only treatment of Onchocerca volvulus in an area of Loa loa co-endemicity: A randomized controlled trial","volume":"4","author":"Turner","year":"2010"},{"key":"b24","series-title":"Clin Infect Dis","first-page":"1199","article-title":"Therapeutic efficacy and macrofilaricidal activity of doxycycline for the treatment of river blindness","volume":"60","author":"Walker","year":"2015"},{"key":"b25","series-title":"Clin Infect Dis","first-page":"517","article-title":"Doxycycline leads to sterility and enhanced killing of female Onchocerca volvulus worms in an area with persistent microfilaridermia after repeated ivermectin treatment: A randomized, placebo-controlled, double-blind trial","volume":"61","author":"Debrah","year":"2015"},{"key":"b26","series-title":"Clin Infect Dis","first-page":"621","article-title":"Doxycycline improves filarial lymphedema independent of active filarial infection: A randomized controlled trial","volume":"55","author":"Mand","year":"2012"},{"key":"b27","series-title":"Am J Trop Med Hyg","article-title":"Effect of adding a six-week course of doxycycline to intensive hygiene-based care for improving lymphedema in a rural setting of mali: A double-blind, randomized controlled 24-month trial","author":"Coulibaly","year":"2024"},{"key":"b28","series-title":"Am J Trop Med Hyg","article-title":"LEDoxy-SL: A placebo-controlled, double-blind, randomized, 24-month trial of six weeks of daily doxycycline plus hygiene-based essential care for reducing progression of filarial lymphedema in Sri Lanka","author":"Yahathugoda"},{"key":"b29","series-title":"Am Trop Med Hyg","first-page":"83","article-title":"Efficacy and safety of adding 6 weeks of doxycycline to the essential package of care to treat filarial lymphedema \u2013 a double blind, randomized controlled trial in Southern India","volume":"111","author":"Krishnasastry"},{"key":"b30","year":"2022"},{"key":"b31","author":"Dreyer","year":"2001"},{"key":"b32","author":"Dreyer","year":"2019"},{"key":"b33","year":"2010"},{"key":"b34","series-title":"PLoS Negl Trop Dis","first-page":"e0007762","article-title":"Portable infrared imaging for longitudinal limb volume monitoring in patients with lymphatic filariasis","volume":"13","author":"Zhou","year":"2019"},{"key":"b35","series-title":"Am J Trop Med Hyg","first-page":"1836","article-title":"Use of a novel portable three-dimensional imaging system to measure limb volume and circumference in patients with filarial lymphedema","volume":"97","author":"Yahathugoda","year":"2017"},{"key":"b36","series-title":"Ann Trop Med Parasitol","first-page":"457","article-title":"Bancroftian filariasis: A comparison of microfilariae counting techniques using counting chamber, standard slide and membrane (Nuclepore) filtration","volume":"73","author":"McMahon","year":"1979"},{"key":"b37","series-title":"J Biomed Inform","first-page":"377","article-title":"Research electronic data capture (REDCap)\u2014A metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009"},{"key":"b38","series-title":"J Biomed Inform","first-page":"103208","article-title":"The REDCap consortium: Building an international community of software platform partners","volume":"95","author":"Harris","year":"2019"},{"key":"b39","series-title":"Ann Stat","first-page":"1100","article-title":"Cox\u2019s regression model for counting processes: A large sample study","volume":"10","author":"Andersen","year":"1982"},{"key":"b40","series-title":"Br J Sports Med","first-page":"1287","article-title":"Statistical modelling for recurrent events: An application to sports injuries","volume":"48","author":"Ullah","year":"2014"},{"key":"b41","series-title":"Curr Opin Infect Dis","first-page":"673","article-title":"Filariasis: New drugs and new opportunities for lymphatic filariasis and onchocerciasis","volume":"21","author":"Hoerauf","year":"2008"},{"key":"b42","series-title":"Lancet","first-page":"1175","article-title":"Lymphatic filariasis and onchocerciasis","volume":"376","author":"Taylor","year":"2010"},{"key":"b43","series-title":"Tanzan J Health Res","first-page":"128","article-title":"Hospital-based safety and tolerability study to assess efficacy of oral doxycycline in the treatment of Wuchereria bancrofti infection in north-eastern Tanzania","volume":"8","author":"Makunde","year":"2009"},{"key":"b44","series-title":"Parasit Vectors","first-page":"53","article-title":"Long term impact of large scale community-directed delivery of doxycycline for the treatment of onchocerciasis","volume":"5","author":"Tamarozzi","year":"2012"},{"key":"b45","series-title":"Clin Infect Dis","first-page":"1081","article-title":"A randomized, double-blind clinical trial of a 3-week course of doxycycline plus albendazole and ivermectin for the treatment of Wuchereria bancrofti infection","volume":"42","author":"Turner","year":"2006"},{"key":"b46","series-title":"Parasitol Res","first-page":"437","article-title":"Efficacy of 5-week doxycycline treatment on adult Onchocerca volvulus","volume":"104","author":"Hoerauf","year":"2009"},{"key":"b47","series-title":"J Parasitol Res","first-page":"201617","article-title":"Macrofilaricidal activity in Wuchereria bancrofti after 2 weeks treatment with a combination of rifampicin plus doxycycline","volume":"2011","author":"Debrah","year":"2011"},{"key":"b48","series-title":"Am Trop Med Hyg","first-page":"66","article-title":"Adherence to hygiene protocols and doxycycline therapy in ameliorating lymphatic filariasis morbidity in an endemic area post-interruption of disease transmission in Ghana","volume":"111","author":"Debrah","year":"2024"},{"key":"b49","series-title":"Filaria J","first-page":"4","article-title":"Lymphoedema: Pathophysiology and management in resource-poor settings\u2014Relevance for lymphatic filariasis control programmes","volume":"2","author":"Vaqas","year":"2003"},{"key":"b50","series-title":"Am J Trop Med Hyg","first-page":"624","article-title":"Effect of a community-based holistic care package on physical and psychosocial outcomes in people with lower limb disorder caused by lymphatic filariasis, podoconiosis, and leprosy in Ethiopia: Results from the EnDPoINT Pilot Cohort Study","volume":"107","author":"Dellar","year":"2022"},{"key":"b51","series-title":"Trans R Soc Trop Med Hyg","first-page":"759","article-title":"Quantifying the physical and socio-economic burden of filarial lymphoedema in Chikwawa District, Malawi","volume":"108","author":"Martindale","year":"2014"},{"key":"b52","series-title":"Int Health","first-page":"iii14","article-title":"Mental health conditions in people affected by filarial lymphoedema in Malawi: Prevalence, associated risk factors and the impact of an enhanced self-care intervention","volume":"15","author":"Barrett","year":"2023"},{"key":"b53","series-title":"BMC Health Serv Res","first-page":"1065","article-title":"A qualitative study on the implementation of a holistic care package for control and management of lymphoedema: Experience from a pilot intervention in northern Ethiopia","volume":"21","author":"Ali","year":"2021"},{"key":"b54","series-title":"PLoS Negl Trop Dis","first-page":"e0004171","article-title":"The effect of hygiene-based lymphedema management in lymphatic filariasis-endemic areas: A systematic review and meta-analysis","volume":"9","author":"Stocks","year":"2015"},{"key":"b55","series-title":"J Clin Med","first-page":"4077","article-title":"Addition of lymphatic stimulating self-care practices reduces acute attacks among people affected by moderate and severe lower-limb lymphedema in Ethiopia, a cluster randomized controlled trial","volume":"9","author":"Douglass","year":"2020"},{"key":"b56","series-title":"PLoS Negl Trop Dis","first-page":"e668","article-title":"Feasibility and effectiveness of basic lymphedema management in Leogane, Haiti, an area endemic for bancroftian filariasis","volume":"4","author":"Addiss","year":"2010"},{"key":"b57","series-title":"Indian J Community Med","first-page":"657","article-title":"Assessment of the impact of morbidity management and disability prevention for lymphatic filariasis on the disease burden in Villupuram district of Tamil Nadu, India","volume":"46","author":"Mathiarasan","year":"2021"},{"key":"b58","series-title":"Trop Biomed","first-page":"66","article-title":"Does the morbidity management and disability prevention (MMDP) clinic serve the filarial lymphedema (FLE) patients\u2019 preeminent expectation?","volume":"37","author":"De Britto","year":"2020"},{"key":"b59","series-title":"J Commun Dis","first-page":"1","article-title":"Management of disability in lymphatic filariasis\u2014An update","volume":"34","author":"Shenoy","year":"2002"},{"key":"b60","series-title":"J Glob Infect Dis","first-page":"227","article-title":"Impact of basic lymphedema management and antifilarial treatment on acute dermatolymphangioadenitis episodes and filarial antigenaemia","volume":"3","author":"El-Nahas","year":"2011"},{"key":"b61","series-title":"Acta Trop","first-page":"19","article-title":"Acute adenolymphangitis due to bancroftian filariasis in Rufiji district, south east Tanzania","volume":"75","author":"Gasarasi","year":"2000"},{"key":"b62","series-title":"PLoS Negl Trop Dis","first-page":"e2716","article-title":"Comparison of three quality of life instruments in lymphatic filariasis: DLQI, WHODAS 2.0, and LFSQQ","volume":"8","author":"Thomas","year":"2014"},{"key":"b63","series-title":"PLoS Negl Trop Dis","first-page":"e2100","article-title":"Impact of community-based lymphedema management on perceived disability among patients with lymphatic filariasis in Orissa State, India","volume":"7","author":"Budge","year":"2013"},{"key":"b64","series-title":"Trans R Soc Trop Med Hyg","first-page":"258","article-title":"Use of the Dermatology Life Quality Index in filarial lymphoedema patients","volume":"100","author":"Babu","year":"2006"},{"key":"b65","series-title":"Acta Trop","first-page":"137","article-title":"Health status of lymphatic filariasis assessed from patients using seven domains five levels (7D5L) instrument","volume":"99","author":"Harichandrakumar","year":"2006"},{"key":"b66","series-title":"Clin Epidemiol Glob Health","first-page":"915","article-title":"A study on \u201cclinical epidemiology of filarial lymphedema patients attending filariasis clinic in Pondicherry\u201d","volume":"8","author":"Singh","year":"2020"}],"container-title":["The American Journal of Tropical Medicine and Hygiene"],"original-title":[],"link":[{"URL":"https:\/\/www.ajtmh.org\/view\/journals\/tpmd\/111\/4_Suppl\/article-p33.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.ajtmh.org\/downloadpdf\/journals\/tpmd\/111\/4_Suppl\/article-p33.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/www.ajtmh.org\/downloadpdf\/journals\/tpmd\/111\/4_Suppl\/article-p33.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,2]],"date-time":"2024-10-02T12:35:43Z","timestamp":1727872543000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ajtmh.org\/view\/journals\/tpmd\/111\/4_Suppl\/article-p33.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,1]]},"references-count":66,"journal-issue":{"issue":"4_Suppl"},"URL":"https:\/\/doi.org\/10.4269\/ajtmh.24-0049","relation":{},"ISSN":["0002-9637","1476-1645"],"issn-type":[{"value":"0002-9637","type":"print"},{"value":"1476-1645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,1]]}}}